None
Quote | Northwest Biotherapeutics Inc. (OTCMKTS:NWBO)
Last: | $0.415 |
---|---|
Change Percent: | 0.49% |
Open: | $0.408 |
Close: | $0.415 |
High: | $0.428 |
Low: | $0.4021 |
Volume: | 1,176,136 |
Last Trade Date Time: | 07/02/2024 03:00:00 am |
News | Northwest Biotherapeutics Inc. (OTCMKTS:NWBO)
Northwest Biotherapeutics Announces Exclusive In-License of Portfolio of Dendritic Cell Technology and Intellectual Property PR Newswire Complementary to Technology & IP Already Owned or In-Licensed; Significant Step in Building a Leading Dendritic Cell Franchise ...
Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...
Message Board Posts | Northwest Biotherapeutics Inc. (OTCMKTS:NWBO)
Subject | By | Source | When |
---|---|---|---|
Dummy | learningcurve2020 | investorshub | 07/02/2024 9:45:17 PM |
Not surprised , that usual folks here will | manibiotech | investorshub | 07/02/2024 9:42:41 PM |
LOL. Anyone starting to ridicule Bigger here you | learningcurve2020 | investorshub | 07/02/2024 9:37:20 PM |
Could Michael Bigger, JF Rule and the rest | Bright Boy | investorshub | 07/02/2024 9:26:23 PM |
Senior Scientist / Associate Director, Omics at insitro | dstock07734 | investorshub | 07/02/2024 9:16:12 PM |
News, Short Squeeze, Breakout and More Instantly...
Northwest Biotherapeutics Inc. Company Name:
NWBO Stock Symbol:
OTCMKTS Market:
Northwest Biotherapeutics Inc. Website:
Northwest Biotherapeutics Announces Exclusive In-License of Portfolio of Dendritic Cell Technology and Intellectual Property PR Newswire Complementary to Technology & IP Already Owned or In-Licensed; Significant Step in Building a Leading Dendritic Cell Franchise ...
Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...
Northwest Biotherapeutics Appoints Seasoned Business Executive and Investor To Its Board of Directors PR Newswire BETHESDA, Md. , March 21, 2024 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax ® ...